We are live on ! Find out more
CLLS

Cellectis

29 hedge funds and large institutions have $23M invested in Cellectis in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $6K | Put options by funds: $3K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

10% more capital invested

Capital invested by funds: $20.9M → $23M (+$2.1M)

7% more funds holding

Funds holding: 2729 (+2)

4.15% more ownership

Funds ownership: 13.55%17.7% (+4.2%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
6
Increased
6
Reduced
6
Closed
4
Calls
$6K
Puts
$3K
Net Calls
+$3K
Net Calls Change
-$7K
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$546 +$565 +303 New
Bank of America
27
Bank of America
North Carolina
$139
PS
28
Principal Securities
Iowa
$94 +$97 +52 New
EWA
29
EverSource Wealth Advisors
Alabama
$23
Principal Financial Group
30
Principal Financial Group
Iowa
-$881K -411,800 Closed
KBC Group
31
KBC Group
Belgium
-$347K -163,447 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
-$27.8K -13,010 Closed
BlackRock
33
BlackRock
New York
-$5.84K -2,755 Closed

CLLS Hedge Fund Activity: Q4 2024 in Review

29 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q4 2024, worth a combined $23M — up 10% from $20.9M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CLLS positions and 4 closed out — a net gain of 2 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $997K. The largest seller was Principal Financial Group, exiting entirely with an estimated $881K sold.

  • 29 institutional investors held Cellectis (CLLS) as of Q4 2024, up from 27 in Q3 2024.
  • Funds reported $23M of Cellectis stock for Q4 2024, up 10% quarter-over-quarter.
  • 6 funds opened new Cellectis positions in Q4 2024 and 4 closed out, a net change of +2 holders.
  • The largest Cellectis buyer in Q4 2024 was Millennium Management, an estimated $997K added.
  • The largest Cellectis seller in Q4 2024 was Principal Financial Group, an estimated $881K sold.

Based on aggregated 13F filings for Q4 2024.